Optimizing Care Closer to Home
“We believe high-quality speciality testing, like treatment, should be close to where a patient resides.”
– Dr. Gang Song, Founder
Leadership Team
Gang Song
Founder and Executive Chairman
Dr. Gang Song is the co-founder and founding CEO of Pillar Biosciences, where he co-invented the SLIMamp® technology and led the company from early research to the first multi-cancer CDx NGS kit to receive PMA approval by FDA. He currently serves as Executive Chairman of the Board at Pillar Biosciences.
Zhaohui Wang, Ph.D.
Co-founder and Chief Scientific Officer
Dr. Zhaohui Wang co-founded Pillar Biosciences, and co-invented SLIMamp technology. Previously, she held positions of increasing responsibility at LabCorp (previously Genzyme Genetics) and IQuum (subsequently acquired by Roche Molecular Diagnostics). Dr. Wang received her Ph.D. in Cellular and Molecular Biology from the University of Massachusetts, Amherst.
Dan Harma
Chief Commercial Officer
Mr. Dan Harma is the Chief Commercial Officer of Pillar Biosciences. He has more than 30 years of experience in the medical device industry, notably in in-vitro diagnostics, molecular diagnostics, and hematology markets. Prior to joining Pillar Biosciences, he served as Chief Commercial Officer at NeuMoDxTM where he led the commercial team and assisted in transitioning the business from research and development stage to full commercialization. Previously, he held multiple roles at Abbott Laboratories, Inc., in both the Diagnostics and Molecular divisions. His positions included oversight of product marketing, sales leadership, and commercial development. Mr. Harma received his MBA from Loyola University and his BBA in Marketing from the University of Wisconsin-Whitewater.
Investors
Board of Directors
Gang Song – Chairman of the Board
Founder
Simone Song – Director
Founder and Senior Partner, ORI Capital
Jianxin Wang – Director
US Chief Executive Officer, Bioperfectus
Shawn Liu – Director
Chairman of the Board, China Biotech Services Holdings Limited
Scientific Advisory Board
Siraj Ali, MD, Ph.D.
VP of Clinical Development, EQRx Inc.
Cheng-Zhong Zhang, Ph.D.
Co-Founder, Pillar. Professor, Harvard Medical School
Marcia Eisenberg, Ph.D.
Chief Scientific Officer, Sr. VP, LabCorp
Timothy Springer, Ph.D.
Professor, Harvard Medical School
Paul M. Waring, MBBS, Ph.D., FRCPA, FRCPath, FHGSA, FFSc(RCPA)
Executive Director, Translational Pathology, AstraZeneca